These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

829 related items for PubMed ID: 16406146

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine.
    Moussa CE, Wersinger C, Tomita Y, Sidhu A.
    Biochemistry; 2004 May 11; 43(18):5539-50. PubMed ID: 15122920
    [Abstract] [Full Text] [Related]

  • 3. Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant.
    Wersinger C, Vernier P, Sidhu A.
    Biochemistry; 2004 Feb 10; 43(5):1242-53. PubMed ID: 14756560
    [Abstract] [Full Text] [Related]

  • 4. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
    Storch A, Hwang YI, Gearhart DA, Beach JW, Neafsey EJ, Collins MA, Schwarz J.
    J Neurochem; 2004 May 10; 89(3):685-94. PubMed ID: 15086525
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.
    Sidhu A, Wersinger C, Vernier P.
    FEBS Lett; 2004 May 07; 565(1-3):1-5. PubMed ID: 15135042
    [Abstract] [Full Text] [Related]

  • 8. G209A mutant alpha synuclein expression specifically enhances dopamine induced oxidative damage.
    Orth M, Tabrizi SJ, Tomlinson C, Messmer K, Korlipara LV, Schapira AH, Cooper JM.
    Neurochem Int; 2004 Oct 07; 45(5):669-76. PubMed ID: 15234109
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Disruption of the interaction of alpha-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter.
    Wersinger C, Sidhu A.
    Biochemistry; 2005 Oct 18; 44(41):13612-24. PubMed ID: 16216085
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dopamine-related and caspase-independent apoptosis in dopaminergic neurons induced by overexpression of human wild type or mutant alpha-synuclein.
    Zhou ZD, Yap BP, Gung AY, Leong SM, Ang ST, Lim TM.
    Exp Cell Res; 2006 Jan 15; 312(2):156-70. PubMed ID: 16297908
    [Abstract] [Full Text] [Related]

  • 16. Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.
    Jiang H, Wu YC, Nakamura M, Liang Y, Tanaka Y, Holmes S, Dawson VL, Dawson TM, Ross CA, Smith WW.
    Neurobiol Aging; 2007 Nov 15; 28(11):1709-17. PubMed ID: 16978743
    [Abstract] [Full Text] [Related]

  • 17. Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice.
    Unger EL, Eve DJ, Perez XA, Reichenbach DK, Xu Y, Lee MK, Andrews AM.
    Neurobiol Dis; 2006 Feb 15; 21(2):431-43. PubMed ID: 16230020
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
    Alvarez-Fischer D, Henze C, Strenzke C, Westrich J, Ferger B, Höglinger GU, Oertel WH, Hartmann A.
    Exp Neurol; 2008 Mar 15; 210(1):182-93. PubMed ID: 18053987
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.